Reuters logo
BRIEF-Summit may get up to $330 mln from Sarepta in specified sales milestones
October 4, 2016 / 11:32 AM / a year ago

BRIEF-Summit may get up to $330 mln from Sarepta in specified sales milestones

Oct 4 (Reuters) - Summit Therapeutics :

* As per deal with Summit Therapeutics, Summit may get up to $330 million from Co in specified sales milestones on product-by-product basis Source text for Eikon: Further company coverage: ;))

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below